THU163 Traffic Light Alerting System For Adherence Risk Management To Improve Catch-Up Growth In Patients Receiving Recombinant Human Growth Hormone Therapy

Disclosure: S. Loche: Advisory Board Member; Self; SL has received advisory board fees from the healthcare business of Merck KGaA, Darmstadt, Germany. Consulting Fee; Self; SL has received consultancy fees from the healthcare business of Merck KGaA, Darmstadt, Germany. Speaker; Self; SL has received...

Descripción completa

Detalles Bibliográficos
Autores principales: Loche, Sandro, van Dommelen, Paula, Koledova, Ekaterina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Pediatric Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555944/
http://dx.doi.org/10.1210/jendso/bvad114.1414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555944/
http://dx.doi.org/10.1210/jendso/bvad114.1414

Ejemplares similares